Inj.rar Official

Mutations in RAR alpha (RARα) are a hallmark of acute promyelocytic leukemia, where RA-based therapies are used to trigger terminal differentiation of cancer cells.

The primary goal of a Rapid Assessment and Response is to generate high-quality public health information under time and resource constraints. Unlike conventional longitudinal studies, RAR focuses on: inj.rar

In a separate biological context, RAR stands for Retinoic Acid Receptors. These are nuclear receptors activated by Vitamin A derivatives that regulate significant biological processes, including cell differentiation and immune response. Mutations in RAR alpha (RARα) are a hallmark